|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/519 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61K 31/506 | (2013.01) |
| (11) | Patento numeris | 3804724 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20203847.7 |
| Europos patento paraiškos padavimo data | 2017-10-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-04-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201662410566 P | 2016-10-20 | US | |
| 201762548629 P | 2017-08-22 | US |
| (72) |
EVANS, Steve Martin , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | CDK INHIBITORS FOR TREATING PAH |
| CDK INHIBITORS FOR TREATING PAH |